DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,665,835 | +6.3% | 212,277 | +2.8% | 1.98% | +8.3% |
Q2 2023 | $49,556,116 | +4.8% | 206,484 | +10.1% | 1.82% | +0.1% |
Q1 2023 | $47,284,043 | +5.1% | 187,605 | +10.7% | 1.82% | -0.8% |
Q4 2022 | $44,979,675 | +7.4% | 169,466 | +4.5% | 1.84% | -4.4% |
Q3 2022 | $41,872,000 | +15181.8% | 162,111 | +14882.5% | 1.92% | +15900.0% |
Q2 2022 | $274,000 | -13.6% | 1,082 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $317,000 | -24.2% | 1,082 | -14.7% | 0.01% | -20.0% |
Q4 2021 | $418,000 | +8.3% | 1,269 | 0.0% | 0.02% | -6.2% |
Q3 2021 | $386,000 | -19.2% | 1,269 | -28.7% | 0.02% | -15.8% |
Q2 2021 | $478,000 | +2.6% | 1,780 | -14.0% | 0.02% | -9.5% |
Q1 2021 | $466,000 | -28.0% | 2,069 | -28.9% | 0.02% | -32.3% |
Q4 2020 | $647,000 | -0.6% | 2,912 | -3.6% | 0.03% | -13.9% |
Q3 2020 | $651,000 | +13.2% | 3,021 | -7.0% | 0.04% | +5.9% |
Q2 2020 | $575,000 | +28.6% | 3,249 | +0.6% | 0.03% | +9.7% |
Q1 2020 | $447,000 | -15.2% | 3,229 | -6.0% | 0.03% | +3.3% |
Q4 2019 | $527,000 | +6.2% | 3,435 | 0.0% | 0.03% | 0.0% |
Q3 2019 | $496,000 | +2.3% | 3,435 | +1.2% | 0.03% | -14.3% |
Q2 2019 | $485,000 | +8.5% | 3,395 | +0.2% | 0.04% | +6.1% |
Q1 2019 | $447,000 | +12.6% | 3,389 | -12.0% | 0.03% | +6.5% |
Q4 2018 | $397,000 | +83.8% | 3,850 | +93.7% | 0.03% | +93.8% |
Q3 2018 | $216,000 | – | 1,988 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |